{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:28:41Z","timestamp":1794925721828,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170755"],"award-info":[{"award-number":["82170755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Diabetic kidney disease (DKD) is a major complication of diabetes and the leading cause of end-stage renal disease worldwide. Renal inflammation and infiltration of immune cells contribute to the development and progression of DKD. Thus, the aim of the present study was to identify and validate immune-related biomarkers and analyze potential regulators including transcription factors (TFs), microRNAs (miRNAs), and drugs for DKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Immune-related genes from the ImmPort database and glomeruli samples from GSE1009 and GSE30528 were used to identify differentially expressed immune-related genes (DEIRGs) of DKD. The expression level and clinical correlation analyses of DEIRGs were verified in the Nephroseq database. Murine podocytes were cultured to construct the high glucose-induced podocyte injury model. The reliability of the bioinformatics analysis was experimentally validated by RT-qPCR in podocytes. Networks among DEIRGs, regulators, and drugs were constructed to predict potential regulatory mechanisms for DKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>DKD-associated DEIRGs were identified. <jats:italic>CCL19<\/jats:italic> and <jats:italic>IL7R<\/jats:italic> were significantly upregulated in the DKD group and negatively correlated with glomerular filtration rate (GFR). <jats:italic>GHR<\/jats:italic>, <jats:italic>FGF1<\/jats:italic>, <jats:italic>FYN<\/jats:italic>, <jats:italic>VEGFA<\/jats:italic>, <jats:italic>F2R<\/jats:italic>, <jats:italic>TGFBR3<\/jats:italic>, <jats:italic>PTGDS<\/jats:italic>, <jats:italic>FGF9<\/jats:italic>, and <jats:italic>SEMA5A<\/jats:italic> were significantly decreased in the DKD group and positively correlated with GFR. RT-qPCR showed that the relative mRNA expression levels of <jats:italic>GHR<\/jats:italic>, <jats:italic>FGF1<\/jats:italic>, <jats:italic>FYN<\/jats:italic>, <jats:italic>TGFBR3<\/jats:italic>, <jats:italic>PTGDS<\/jats:italic>, <jats:italic>FGF9<\/jats:italic>, and <jats:italic>SEMA5A<\/jats:italic> were significantly down-regulated in the high glucose-induced podocyte injury group. The enriched regulators for DEIRGs included 110 miRNAs and 8 TFs. The abnormal expression of DEIRGs could be regulated by 16 established drugs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study identified immune-related biomarkers, regulators, and drugs of DKD. The findings of the present study provide novel insights into immune-related diagnosis and treatment of DKD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-023-01519-6","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T09:02:18Z","timestamp":1682931738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Identification and validation of immune-related biomarkers and potential regulators and therapeutic targets for diabetic kidney disease"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0635-7724","authenticated-orcid":false,"given":"Shengnan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9262-6112","authenticated-orcid":false,"given":"Hongli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"key":"1519_CR1","doi-asserted-by":"publisher","first-page":"586892","DOI":"10.3389\/fphar.2020.586892","volume":"11","author":"C Zoja","year":"2020","unstructured":"Zoja C, Xinaris C, Macconi D. Diabetic nephropathy: novel molecular mechanisms and therapeutic targets. Front Pharmacol. 2020;11:586892.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1519_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41581-019-0234-4","volume":"16","author":"SCW Tang","year":"2020","unstructured":"Tang SCW, Yiu WH. Innate immunity in diabetic kidney disease. Nat Rev Nephrol. 2020;16(4):206\u201322.","journal-title":"Nat Rev Nephrol"},{"issue":"5871","key":"1519_CR3","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1126\/science.1151651","volume":"319","author":"O Hobert","year":"2008","unstructured":"Hobert O. Gene regulation by transcription factors and microRNAs. Science. 2008;319(5871):1785\u20136.","journal-title":"Science"},{"issue":"4","key":"1519_CR4","doi-asserted-by":"publisher","first-page":"e0214857","DOI":"10.1371\/journal.pone.0214857","volume":"14","author":"S Li","year":"2019","unstructured":"Li S, Cao Y, Li L, Zhang H, Lu X, Bo C, Kong X, Liu Z, Chen L, Liu P, Jiao Y, Wang J, Ning S, Wang L. Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis. PLoS ONE. 2019;14(4):e0214857.","journal-title":"PLoS ONE"},{"key":"1519_CR5","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.12659\/MSM.911714","volume":"25","author":"T Zhang","year":"2019","unstructured":"Zhang T, Chi Y, Ren Y, Du C, Shi Y, Li Y. Resveratrol reduces oxidative stress and apoptosis in podocytes via Sir2-related enzymes, sirtuins1 (SIRT1)\/peroxisome proliferator-activated receptor \u03b3 co-activator 1\u03b1 (PGC-1\u03b1) axis. Med Sci Monit. 2019;25:1220\u201331.","journal-title":"Med Sci Monit"},{"issue":"11","key":"1519_CR6","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1111\/jcmm.13189","volume":"21","author":"M Hu","year":"2017","unstructured":"Hu M, Wang R, Li X, Fan M, Lin J, Zhen J, Chen L, Lv Z. LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with \u03b2-catenin. J Cell Mol Med. 2017;21(11):2732\u201347.","journal-title":"J Cell Mol Med"},{"key":"1519_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol. 2016;1418:93\u2013110.","journal-title":"Methods Mol Biol"},{"key":"1519_CR8","doi-asserted-by":"publisher","first-page":"180015","DOI":"10.1038\/sdata.2018.15","volume":"5","author":"S Bhattacharya","year":"2018","unstructured":"Bhattacharya S, Dunn P, Thomas CG, Smith B, Schaefer H, Chen J, Hu Z, Zalocusky KA, Shankar RD, Shen-Orr SS, Thomson E, Wiser J, Butte AJ. ImmPort, toward repurposing of open access immunological assay data for translational and clinical research. Sci Data. 2018;5:180015.","journal-title":"Sci Data"},{"issue":"7","key":"1519_CR9","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47\u2013e47.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1519_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2105-15-293","volume":"15","author":"P Bardou","year":"2014","unstructured":"Bardou P, Mariette J, Escudi\u00e9 F, Djemiel C, Klopp C. jvenn: an interactive Venn diagram viewer. BMC Bioinform. 2014;15(1):293.","journal-title":"BMC Bioinform"},{"issue":"5","key":"1519_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jbi.2011.05.002","volume":"44","author":"H Dweep","year":"2011","unstructured":"Dweep H, Sticht C, Pandey P, Gretz N. miRWalk\u2013database: prediction of possible miRNA binding sites by \u201cwalking\u201d the genes of three genomes. J Biomed Inform. 2011;44(5):839\u201347.","journal-title":"J Biomed Inform"},{"key":"1519_CR12","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.","journal-title":"Elife"},{"issue":"D1","key":"1519_CR13","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127-d131.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"1519_CR14","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47(W1):W234\u201341.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"1519_CR15","doi-asserted-by":"publisher","first-page":"W212","DOI":"10.1093\/nar\/gkz446","volume":"47","author":"AB Keenan","year":"2019","unstructured":"Keenan AB, Torre D, Lachmann A, Leong AK, Wojciechowicz ML, Utti V, Jagodnik KM, Kropiwnicki E, Wang Z. Ma\u2019ayan A: ChEA3: transcription factor enrichment analysis by orthogonal omics integration. Nucleic Acids Res. 2019;47(W1):W212\u201324.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1519_CR16","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon JA, Riudavets-Puig R, Rauluseviciute I, Lemma RB, Turchi L, Blanc-Mathieu R, Lucas J, Boddie P, Khan A, Manosalva P\u00e9rez N, Fornes O, Leung TY, Aguirre A, Hammal F, Schmelter D, Baranasic D, Ballester B, Sandelin A, Lenhard B, Vandepoele K, Wasserman WW, Parcy F, Mathelier A. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2022;50(D1):D165-d173.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1519_CR17","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2021","unstructured":"Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, Mattingly CJ. Comparative Toxicogenomics Database (CTD): update 2021. Nucleic Acids Res. 2021;49(D1):D1138\u201343.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"1519_CR18","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1042\/CS20160636","volume":"131","author":"GH Tesch","year":"2017","unstructured":"Tesch GH. Diabetic nephropathy\u2014is this an immune disorder? Clin Sci (Lond). 2017;131(16):2183\u201399.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"1519_CR19","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/s41467-019-11013-2","volume":"10","author":"H Lazareth","year":"2019","unstructured":"Lazareth H, Henique C, Lenoir O, Puelles VG, Flamant M, Boll\u00e9e G, Fligny C, Camus M, Guyonnet L, Millien C, Gaillard F, Chipont A, Robin B, Fabrega S, Dhaun N, Camerer E, Kretz O, Grahammer F, Braun F, Huber TB, Nochy D, Mandet C, Bruneval P, Mesnard L, Thervet E, Karras A, Le Naour F, Rubinstein E, Boucheix C, Alexandrou A, Moeller MJ, Bouzigues C, Tharaux P-L. The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression. Nat Commun. 2019;10(1):3303.","journal-title":"Nat Commun"},{"key":"1519_CR20","doi-asserted-by":"publisher","first-page":"146154","DOI":"10.1155\/2012\/146154","volume":"2012","author":"AKH Lim","year":"2012","unstructured":"Lim AKH, Tesch GH. Inflammation in diabetic nephropathy. Mediat Inflamm. 2012;2012:146154.","journal-title":"Mediat Inflamm"},{"issue":"4","key":"1519_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41419-021-03643-6","volume":"12","author":"R Nishad","year":"2021","unstructured":"Nishad R, Mukhi D, Singh AK, Motrapu M, Chintala K, Tammineni P, Pasupulati AK. Growth hormone induces mitotic catastrophe of glomerular podocytes and contributes to proteinuria. Cell Death Dis. 2021;12(4):342.","journal-title":"Cell Death Dis"},{"key":"1519_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ghir.2019.07.001","volume":"48\u201349","author":"AL Brittain","year":"2019","unstructured":"Brittain AL, Kopchick JJ. A review of renal GH\/IGF1 family gene expression in chronic kidney diseases. Growth Horm IGF Res. 2019;48\u201349:1\u20134.","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"1519_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ando.2011.08.001","volume":"72","author":"S Grunenwald","year":"2011","unstructured":"Grunenwald S, Tack I, Chauveau D, Bennet A, Caron P. Impact of growth hormone hypersecretion on the adult human kidney. Ann Endocrinol (Paris). 2011;72(6):485\u201395.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"1519_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.kint.2017.05.013","volume":"93","author":"G Liang","year":"2018","unstructured":"Liang G, Song L, Chen Z, Qian Y, Xie J, Zhao L, Lin Q, Zhu G, Tan Y, Li X, Mohammadi M, Huang Z. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism. Kidney Int. 2018;93(1):95\u2013109.","journal-title":"Kidney Int"},{"key":"1519_CR25","doi-asserted-by":"publisher","first-page":"690535","DOI":"10.3389\/fphar.2021.690535","volume":"12","author":"D Wang","year":"2021","unstructured":"Wang D, Zhao T, Zhao Y, Yin Y, Huang Y, Cheng Z, Wang B, Liu S, Pan M, Sun D, Wang Z, Zhu G. PPAR\u03b3 mediates the anti-epithelial-mesenchymal transition effects of FGF1(\u0394HBS) in chronic kidney diseases via inhibition of TGF-\u03b21\/SMAD3 signaling. Front Pharmacol. 2021;12:690535.","journal-title":"Front Pharmacol"},{"key":"1519_CR26","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2015.08.011","volume":"89","author":"JI Chuang","year":"2015","unstructured":"Chuang JI, Huang JY, Tsai SJ, Sun HS, Yang SH, Chuang PC, Huang BM, Ching CH. FGF9-induced changes in cellular redox status and HO-1 upregulation are FGFR-dependent and proceed through both ERK and AKT to induce CREB and Nrf2 activation. Free Radic Biol Med. 2015;89:274\u201386.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1519_CR27","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.bbrc.2019.10.175","volume":"521","author":"J Sun","year":"2020","unstructured":"Sun J, Wang Z, Shi H, Gu L, Wang S, Wang H, Li Y, Wei T, Wang Q, Wang L. LncRNA FAF inhibits fibrosis induced by angiotensinogen II via the TGF\u03b21-P-Smad2\/3 signalling by targeting FGF9 in cardiac fibroblasts. Biochem Biophys Res Commun. 2020;521(3):814\u201320.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1519_CR28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.7150\/ijbs.40643","volume":"16","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Zhang X, Ma F, Sun W, Wang W, Yu J, Shi Y, Cai L, Xu Z. The role of Akt2 in the protective effect of fenofibrate against diabetic nephropathy. Int J Biol Sci. 2020;16(4):553\u201367.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"1519_CR29","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jnutbio.2014.12.008","volume":"26","author":"G Shang","year":"2015","unstructured":"Shang G, Tang X, Gao P, Guo F, Liu H, Zhao Z, Chen Q, Jiang T, Zhang N, Li H. Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta\/Fyn\/Nrf2 signaling pathway. J Nutr Biochem. 2015;26(6):596\u2013606.","journal-title":"J Nutr Biochem"},{"issue":"10","key":"1519_CR30","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.bbalip.2015.07.001","volume":"1851","author":"SS Xue","year":"2015","unstructured":"Xue SS, He JL, Zhang X, Liu YJ, Xue FX, Wang CJ, Ai D, Zhu Y. Metabolomic analysis revealed the role of DNA methylation in the balance of arachidonic acid metabolism and endothelial activation. Biochim Biophys Acta. 2015;1851(10):1317\u201326.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"1519_CR31","doi-asserted-by":"publisher","first-page":"e13197","DOI":"10.1111\/acel.13197","volume":"19","author":"CA Reynolds","year":"2020","unstructured":"Reynolds CA, Tan Q, Munoz E, Jylh\u00e4v\u00e4 J, Hjelmborg J, Christiansen L, H\u00e4gg S, Pedersen NL. A decade of epigenetic change in aging twins: genetic and environmental contributions to longitudinal DNA methylation. Aging Cell. 2020;19(8):e13197.","journal-title":"Aging Cell"},{"key":"1519_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12976-015-0008-z","volume":"12","author":"MC \u00c1lvarez-Silva","year":"2015","unstructured":"\u00c1lvarez-Silva MC, Yepes S, Torres MM, Barrios AF. Proteins interaction network and modeling of IGVH mutational status in chronic lymphocytic leukemia. Theor Biol Med Model. 2015;12:12.","journal-title":"Theor Biol Med Model"},{"issue":"15","key":"1519_CR33","doi-asserted-by":"publisher","first-page":"7881","DOI":"10.3390\/ijms22157881","volume":"22","author":"L Wang","year":"2021","unstructured":"Wang L, Wang HL, Liu TT, Lan HY. TGF-beta as a master regulator of diabetic nephropathy. Int J Mol Sci. 2021;22(15):7881.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1519_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.kint.2021.10.023","volume":"101","author":"Q Hong","year":"2022","unstructured":"Hong Q, Cai H, Zhang L, Li Z, Zhong F, Ni Z, Cai G, Chen XM, He JC, Lee K. Modulation of transforming growth factor-\u03b2-induced kidney fibrosis by leucine-rich \u237a-2 glycoprotein-1. Kidney Int. 2022;101(2):299\u2013314.","journal-title":"Kidney Int"},{"issue":"1","key":"1519_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mvr.2009.10.005","volume":"79","author":"A Sadanandam","year":"2010","unstructured":"Sadanandam A, Rosenbaugh EG, Singh S, Varney M, Singh RK. Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis. Microvasc Res. 2010;79(1):1\u20139.","journal-title":"Microvasc Res"},{"issue":"1","key":"1519_CR36","doi-asserted-by":"publisher","first-page":"1902099","DOI":"10.1002\/advs.201902099","volume":"7","author":"W Chen","year":"2019","unstructured":"Chen W, Chen H, Zheng D, Zhang H, Deng L, Cui W, Zhang Y, Santos HA, Shen H. Gene-hydrogel microenvironment regulates extracellular matrix metabolism balance in nucleus pulposus. Adv Sci (Weinh). 2019;7(1):1902099\u20131902099.","journal-title":"Adv Sci (Weinh)"},{"key":"1519_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41438-019-0122-x","volume":"6","author":"Y Gao","year":"2019","unstructured":"Gao Y, Zhu N, Zhu X, Wu M, Jiang C-Z, Grierson D, Luo Y, Shen W, Zhong S, Fu D-Q, Qu G. Diversity and redundancy of the ripening regulatory networks revealed by the fruitENCODE and the new CRISPR\/Cas9 and mutants. Hortic Res. 2019;6:39.","journal-title":"Hortic Res"},{"issue":"9","key":"1519_CR38","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1002\/jcp.30305","volume":"236","author":"J-C Cheng","year":"2021","unstructured":"Cheng J-C, Fang L, Yan Y, He J, Guo Y, Jia Q, Gao Y, Han X, Sun Y-P. TGF-\u03b21 stimulates aromatase expression and estradiol production through SMAD2 and ERK1\/2 signaling pathways in human granulosa-lutein cells. J Cell Physiol. 2021;236(9):6619\u201329.","journal-title":"J Cell Physiol"},{"issue":"Suppl A","key":"1519_CR39","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1016\/j.genm.2008.03.010","volume":"5","author":"C Maric","year":"2008","unstructured":"Maric C, Sullivan S. Estrogens and the diabetic kidney. Gend Med. 2008;5(Suppl A):S103\u201313.","journal-title":"Gend Med"},{"issue":"10","key":"1519_CR40","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1681\/ASN.2015070741","volume":"27","author":"A Inada","year":"2016","unstructured":"Inada A, Inada O, Fujii NL, Nagafuchi S, Katsuta H, Yasunami Y, Matsubara T, Arai H, Fukatsu A, Nabeshima Y-I. Adjusting the 17\u03b2-estradiol-to-androgen ratio ameliorates diabetic nephropathy. J Am Soc Nephrol. 2016;27(10):3035\u201350.","journal-title":"J Am Soc Nephrol"},{"key":"1519_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13098-015-0097-1","volume":"7","author":"B Al-Trad","year":"2015","unstructured":"Al-Trad B, Ashankyty IM, Alaraj M. Progesterone ameliorates diabetic nephropathy in streptozotocin-induced diabetic Rats. Diabetol Metab Syndr. 2015;7:97.","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"1519_CR42","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1681\/ASN.2014070678","volume":"26","author":"H Xu","year":"2015","unstructured":"Xu H, Wu X, Qin H, Tian W, Chen J, Sun L, Fang M, Xu Y. Myocardin-related transcription factor a epigenetically regulates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol. 2015;26(7):1648\u201360.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1519_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1550-8579(05)80052-X","volume":"2","author":"CC Wells","year":"2005","unstructured":"Wells CC, Riazi S, Mankhey RW, Bhatti F, Ecelbarger C, Maric C. Diabetic nephropathy is associated with decreased circulating estradiol levels and imbalance in the expression of renal estrogen receptors. Gend Med. 2005;2(4):227\u201337.","journal-title":"Gend Med"},{"issue":"11","key":"1519_CR44","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/ki.2009.69","volume":"75","author":"P Catanuto","year":"2009","unstructured":"Catanuto P, Doublier S, Lupia E, Fornoni A, Berho M, Karl M, Striker GE, Xia X, Elliot S. 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int. 2009;75(11):1194\u2013201.","journal-title":"Kidney Int"},{"issue":"1","key":"1519_CR45","first-page":"1","volume":"67","author":"F Parazzini","year":"2015","unstructured":"Parazzini F. Resveratrol, tryptophanum, glycine and vitamin E: a nutraceutical approach to sleep disturbance and irritability in peri- and post-menopause. Minerva Ginecol. 2015;67(1):1\u20135.","journal-title":"Minerva Ginecol"},{"issue":"10","key":"1519_CR46","doi-asserted-by":"publisher","first-page":"e0204499","DOI":"10.1371\/journal.pone.0204499","volume":"13","author":"Y Li","year":"2018","unstructured":"Li Y, Huang J, Yan Y, Liang J, Liang Q, Lu Y, Zhao L, Li H. Preventative effects of resveratrol and estradiol on streptozotocin-induced diabetes in ovariectomized mice and the related mechanisms. PLoS ONE. 2018;13(10):e0204499.","journal-title":"PLoS ONE"},{"key":"1519_CR47","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3389\/fphar.2020.01249","volume":"11","author":"T-T Cai","year":"2020","unstructured":"Cai T-T, Ye X-L, Li R-R, Chen H, Wang Y-Y, Yong H-J, Pan M-L, Lu W, Tang Y, Miao H, Snijders AM, Mao J-H, Liu X-Y, Lu Y-B, Ding D-F. Resveratrol modulates the gut microbiota and inflammation to protect against diabetic nephropathy in mice. Front Pharmacol. 2020;11:1249.","journal-title":"Front Pharmacol"},{"key":"1519_CR48","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2741\/4829","volume":"25","author":"H Zhu","year":"2020","unstructured":"Zhu H, Zhong S, Yan H, Wang K, Chen L, Zhou M, Li Y. Resveratrol reverts Streptozotocin-induced diabetic nephropathy. Front Biosci (Landmark Ed). 2020;25:699\u2013709.","journal-title":"Front Biosci (Landmark Ed)"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01519-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01519-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01519-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T10:06:15Z","timestamp":1682935575000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01519-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1519"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01519-6","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author has no competing interests in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}